Search Results - Ke Szeto
- Showing 1 - 1 results of 1
-
1
Evaluation of the cardiac safety of parsaclisib, a selective PI3Kδ inhibitor, in patients with previously treated B‐cell malignancies: Results from the CITADEL‐101 study by Jia Li, Xiaohua Gong, Xing Liu, Xiang Liu, Ke Szeto, Xuejun Chen
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book